Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy Evaluation of Modified Zhixiao Tongmai Ning in Preventing Radiation-Induced Kidney Injury in Cancer Patients

NCT07849088 is registered in ClinicalTrials.gov with Peking University First Hospital as lead sponsor.

NCT NCT07849088
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07849088 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy Evaluation of Modified Zhixiao Tongmai Ning in Preventing Radiation-Induced Kidney Injury in Cancer Patients
Lead sponsor
Peking University First Hospital
Phase
Phase 2
Overall status
Recruiting
Start date
August 11, 2026
Completion date
June 1, 2029
Enrollment
194 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer patients receiving radiotherapy for kidney malignancies